Eco R1 Capital, LLC Portfolio Holdings

Eco R1 Capital, LLC

  • $2.14 Billion
  • Q4 2024

Eco R1 Capital, LLC has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $2.14 Billion distributed in 59 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Apellis Pharmaceuticals, Inc. with a value of $379M, Crinetics Pharmaceuticals, Inc. with a value of $219M, Jazz Pharmaceuticals PLC with a value of $210M, Prothena Corp Public LTD CO with a value of $160M, and Xencor Inc with a value of $141M.

Examining the 13F form we can see an decrease of $165M in the current position value, from $2.31B to 2.14B.

Eco R1 Capital, LLC is based out at San Francisco, CA

Below you can find more details about Eco R1 Capital, LLC portfolio as well as his latest detailed transactions.

Portfolio value $2.14 Billion
Healthcare: $2.14 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$2.11B
$379 Million 17.73% of portfolio
11,890,843
Q3 2024 Added 2.44%
$1.79B
$219 Million 10.24% of portfolio
4,288,120
Q3 2024 Added 3.19%
$7.33B
$210 Million 9.82% of portfolio
1,706,469
Q3 2024 Added 68.3%
$432M
$160 Million 7.5% of portfolio
11,584,280
Q1 2022 Added 2.66%
$658M
$141 Million 6.6% of portfolio
6,144,767
Q4 2024 Added 15.28%
$512M
$129 Million 6.03% of portfolio
6,726,491
Q4 2023 Added 23.04%
$5.46B
$93.6 Million 4.37% of portfolio
770,000
Q4 2024 New
$1.38B
$78.7 Million 3.68% of portfolio
1,469,818
Q2 2024 New
$690M
$60 Million 2.81% of portfolio
3,400,000
Q4 2024 New
$2.89B
$56.4 Million 2.63% of portfolio
1,560,000
Q4 2024 New
$3.02B
$54.7 Million 2.55% of portfolio
1,389,276
Q1 2024 New
$108M
$39.8 Million 1.86% of portfolio
3,879,415
Q4 2023 New
$208M
$32.7 Million 1.53% of portfolio
3,182,444
Q4 2023 Added 6.71%
$124M
$32.8 Million 1.53% of portfolio
10,630,736
Q4 2024 Reduced 20.25%
$439M
$31 Million 1.45% of portfolio
3,557,269
Q4 2024 Reduced 38.74%
$225M
$27.6 Million 1.29% of portfolio
3,418,068
Q1 2022 Reduced 1.47%
$5.71B
$23.1 Million 1.08% of portfolio
75,000
Q1 2024 New
$136M
$22.2 Million 1.04% of portfolio
3,917,546
Q1 2024 Added 1.71%
$1.48B
$17.7 Million 0.83% of portfolio
332,522
Q4 2024 New
$35M
$16.2 Million 0.76% of portfolio
11,328,000
Q4 2024 Reduced 41.5%
$1.7B
$16.2 Million 0.76% of portfolio
557,576
Q4 2024 Reduced 26.4%
$29.3M
$15.1 Million 0.71% of portfolio
5,000,000
Q2 2023 New
$44.1M
$14.8 Million 0.69% of portfolio
27,404,070
Q1 2024 New
$1.87B
$14.1 Million 0.66% of portfolio
350,000
Q4 2024 New
$610M
$13.1 Million 0.61% of portfolio
555,644
Q3 2024 Added 30.12%
$254M
$12.7 Million 0.6% of portfolio
910,000
Q2 2024 New
$246M
$11.2 Million 0.52% of portfolio
3,341,653
Q4 2024 Reduced 38.59%
$572M
$10.9 Million 0.51% of portfolio
862,068
Q3 2024 New
$482M
$10.3 Million 0.48% of portfolio
850,341
Q2 2024 New
$340M
$7.05 Million 0.33% of portfolio
1,250,000
Q4 2023 New
$124M
$5.03 Million 0.24% of portfolio
3,049,405
Q4 2024 New
$1.77B
$4.26 Million 0.2% of portfolio
155,006
Q3 2024 Reduced 97.31%
$372M
$2.97 Million 0.14% of portfolio
187,500
Q1 2024 New
$271M
$2.63 Million 0.12% of portfolio
426,683
Q4 2024 Added 692.59%
$400M
$2.64 Million 0.12% of portfolio
641,426
Q4 2024 Reduced 74.34%
$25.4M
$2.17 Million 0.1% of portfolio
2,046,867
Q2 2023 Added 4.61%
$155M
$2.04 Million 0.1% of portfolio
700,000
Q1 2024 New
$35.9M
$1.09 Million 0.05% of portfolio
345,253
Q4 2024 Reduced 81.29%
$913M
$171,000 0.01% of portfolio
408,688
Q4 2024 Reduced 96.38%
Upstream Bio Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
Aligos Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Anaptysbio Inc
-
$0 0.0% of portfolio
-
Q4 2024 Added 1.01%
Artiva Biotherapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Atara Biotherapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 Added 13.48%
Tectonic Therapeutic Inc
-
$0 0.0% of portfolio
-
Q2 2024 New
Cargo Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2024 New
$0
$1,000 0.0% of portfolio
66,665
Q3 2021 New
Ginkgo Bioworks Holdings Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
Hookipa Pharma Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 31.98%

Summary

  • Portfolio
  • No. of Stocks 59
  • Current Value $2.14 Billion
  • Prior Value $2.31 Billion
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 8 stocks
  • Additional Purchases 7 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 9 stocks
Track This Portfolio

Track Eco R1 Capital, LLC Portfolio

Follow Eco R1 Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eco R1 Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email